162 related articles for article (PubMed ID: 33277966)
1. Prognostic value of lipid metabolism-related genes in head and neck squamous cell carcinoma.
Xiong Y; Si Y; Feng Y; Zhuo S; Cui B; Zhang Z
Immun Inflamm Dis; 2021 Mar; 9(1):196-209. PubMed ID: 33277966
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatic analysis and verification of a lipid metabolism-related long noncoding RNA prognostic signature for head and neck squamous cell carcinoma.
Yuan LY; Chen X; Pan KW; He Y; Li HY; Yu DS
Cell Signal; 2023 Dec; 112():110903. PubMed ID: 37813294
[TBL] [Abstract][Full Text] [Related]
3. Identification of two distinct head and neck squamous cell carcinoma subtypes based on fatty acid metabolism-related signatures: Implications for immunotherapy and chemotherapy.
Zou J; Dai Y; Xu G; Kai Y; Lan L; Zhang J; Wang Y
Medicine (Baltimore); 2024 Apr; 103(16):e37824. PubMed ID: 38640298
[TBL] [Abstract][Full Text] [Related]
4. The Potential of Lipid Droplet-associated Genes as Diagnostic and Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma.
Bai YT; Wang X; He MJ; Xie JR; Chen XJ; Zhou G
Comb Chem High Throughput Screen; 2024; 27(1):136-147. PubMed ID: 36998140
[TBL] [Abstract][Full Text] [Related]
5. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S
Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682
[TBL] [Abstract][Full Text] [Related]
6. Investigating diagnostic potential of long non-coding RNAs in head and neck squamous cell carcinoma using TCGA database and clinical specimens.
Lan T; Yan Y; Zheng D; Ding L
Sci Rep; 2024 Mar; 14(1):7500. PubMed ID: 38553620
[TBL] [Abstract][Full Text] [Related]
7. Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.
Wu YC; Huang CS; Hsieh MS; Huang CM; Setiawan SA; Yeh CT; Kuo KT; Liu SC
Aging (Albany NY); 2024 Jan; 16(1):627-647. PubMed ID: 38206305
[TBL] [Abstract][Full Text] [Related]
8. A prognostic model based on Scissor
Tian G; Zhang J; Bao Y; Li Q; Hou J
Cell Signal; 2024 Feb; 114():110984. PubMed ID: 38029947
[TBL] [Abstract][Full Text] [Related]
9. Y-Chromosome-Linked Genes Are Associated With Sex-Related Head-Neck Squamous Cell Carcinoma Survival.
Feng X; Zhang T; Chou J; Patwa HS; Sullivan CA; Browne JD
Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1533-1541. PubMed ID: 37418217
[TBL] [Abstract][Full Text] [Related]
10. CERCAM is a prognostic biomarker associated with immune infiltration of macrophage M2 polarization in head and neck squamous carcinoma.
Yang Y; Yan C; Chen XJ
BMC Oral Health; 2023 Oct; 23(1):724. PubMed ID: 37803318
[TBL] [Abstract][Full Text] [Related]
11. Exploring NK-Cell molecules that impact the immune response and microenvironment in head and neck squamous cell carcinoma.
Shao P; Hu WW; Shi XL; Shu MY; Li DY; Zhou T; Zhao QT
J Cell Mol Med; 2024 Jan; 28(2):e18045. PubMed ID: 38011007
[TBL] [Abstract][Full Text] [Related]
12. Construction and validation of a folate metabolism-related gene signature for predicting prognosis in HNSCC.
Wang L; He Y; Bai Y; Zhang S; Pang B; Chen A; Wu X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):198. PubMed ID: 38625586
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial-related genes markers that predict survival in patients with head and neck squamous cell carcinoma affect immunomodulation through hypoxia, glycolysis, and angiogenesis pathways.
Li Z; Cai H; Zheng J; Chen X; Liu G; Lv Y; Ye H; Cai G
Aging (Albany NY); 2023 Oct; 15(19):10347-10369. PubMed ID: 37796226
[TBL] [Abstract][Full Text] [Related]
14. Identification of Metabolism-Related Prognostic Biomarkers and Immune Features of Head and Neck Squamous Cell Carcinoma.
Zhou R; Wang J
Crit Rev Immunol; 2024; 44(4):61-78. PubMed ID: 38505922
[TBL] [Abstract][Full Text] [Related]
15. A novel oxidative stress-related gene signature as an indicator of prognosis and immunotherapy responses in HNSCC.
Li Z; Zheng C; Liu H; Lv J; Wang Y; Zhang K; Kong S; Chen F; Kong Y; Yang X; Cheng Y; Yang Z; Zhang C; Tian Y
Aging (Albany NY); 2023 Dec; 15(24):14957-14984. PubMed ID: 38157249
[TBL] [Abstract][Full Text] [Related]
16. CXC ligand 13 orchestrates an immunoactive microenvironment and enhances immunotherapy response in head and neck squamous cell carcinoma.
Lin X; Zhao X; Chen Y; Yang R; Dai Z; Li W; Lin C; Cao W
Int J Immunopathol Pharmacol; 2024; 38():3946320241227312. PubMed ID: 38252495
[No Abstract] [Full Text] [Related]
17. RNA 5-Methylcytosine Regulator NSUN3 promotes tumor progression through regulating immune infiltration in head and neck squamous cell carcinoma.
Jin S; Li J; Shen Y; Wu Y; Zhang Z; Ma H
Oral Dis; 2024 Mar; 30(2):313-328. PubMed ID: 35997137
[TBL] [Abstract][Full Text] [Related]
18. Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC.
Li C; Guan R; Li W; Wei D; Cao S; Chang F; Wei Q; Wei R; Chen L; Xu C; Wu K; Lei D
BMC Cancer; 2023 Sep; 23(1):840. PubMed ID: 37679666
[TBL] [Abstract][Full Text] [Related]
19. Multi-omics analysis of immune-related microbiome and prognostic model in head and neck squamous cell carcinoma.
Liu Y; Lin H; Zhong W; Zeng Y; Zhou G; Chen Z; Huang S; Zhang L; Liu X
Clin Oral Investig; 2024 Apr; 28(5):263. PubMed ID: 38642188
[TBL] [Abstract][Full Text] [Related]
20. Potential Role of the Intratumoral Microbiota in Prognosis of Head and Neck Cancer.
Hamada M; Inaba H; Nishiyama K; Yoshida S; Yura Y; Matsumoto-Nakano M; Uzawa N
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
